Nerve growth factor therapy for corneal disease

Current Opinion in Ophthalmology

Volumn 23, Issue 4, 2012, Pages 296-302

  Lambiase, Alessandro ^a   Sacchetti, Marta ^a   Bonini, Stefano ^a  

^a UNIVERSITY OF ROME   (Italy)

Author keywords

cornea; dry eye; immune keratitis; nerve growth factor; neurotrophic keratitis

Indexed keywords

EYE DROPS; NERVE GROWTH FACTOR; NEUROTROPHIN; RECOMBINANT NERVE GROWTH FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CORNEA DISEASE; CORNEA SENSIBILITY; CORNEA SURGERY; DRY EYE; HERPES SIMPLEX KERATITIS; HUMAN; IMMUNOMODULATION; KERATITIS; KERATOPATHY; NEUROTROPHIC KERATITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TEAR FILM;

ANIMALS; CORNEAL DISEASES; HUMANS; NERVE GROWTH FACTOR;

EID: 84862580753     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283543b61     Document Type: Article

References (56)

1. ChaoMV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006; 110:167-173.
2. Aloe L, Tirassa P, Bracci-Laudiero L. Nerve growth factor in neurological and nonneurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des 2001; 7:113-123.
3. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237:1154-1162.
4. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001; 24:1217-1281.
5. Aloe L, Simone MD, Properzi F. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc Res Tech 1999; 45:285-291.
6. Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcers. Pharmacol Res 2008; 57:253-258.
7. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338: 1174-1180.
8. Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000; 107:1347-1355.
9. Bonini S, RasiG, Bracci-LaudieroML, et al. Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol 2002; 131:80-84.
10. Bonini S, Aloe L, Bonini S, et al. Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface. Adv Exp Med Biol 2002; 506:531-537.
11. Lambiase A, Bonini S, Aloe L, et al. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 2000; 118:1446-1449.
12. Lambiase A, Coassin M, Sposato V, et al. NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies. Pharmacol Res 2007; 56:65-69.
13. Qi H, Li DQ, Shine HD, et al. Nerve growth factor and its receptor TrkA serve as potential markers for human corneal epithelial progenitor cells. Exp Eye Res 2008; 86:34-40.
14. Touhami A, Grueterich M, Tseng SC. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci 2002; 43:987-994.
15. Lambiase A, Coassin M, Costa N, et al. Topical treatment with nerve growth factor in an animal model of herpetic keratitis. Graefes Arch Clin Exp Ophthalmol 2008; 246:121-127.
16. Lambiase A, Micera A, Sacchetti M, et al. Alterations of tear neuromediators in dry eye disease. Arch Ophthalmol 2011; 129:981-986. This article highlights the role of neuromediators and neurotrophins in dry eye patients. The authors demonstrated decreased tear levels of NPY and CGRP and increase of NGF in dry eye disease, suggesting that NPY, CGRP, and NGF could become useful markers of dry eye severity.
17. Gong N, Pleyer U, Vogt K, et al. Local overexpression of nerve growth factor in rat corneal transplants improves allograft survival. Invest Ophthalmol Vis Sci 2007; 48:1043-1052.
18. Lambiase A, Manni L, Bonini S, et al. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 2000; 41:1063-1069.
19. Lambiase A, Bonini S, Manni L, et al. Intraocular production and release of nerve growth factor after iridectomy. Invest Ophthalmol Vis Sci 2002; 43: 2334-2340.
20. You L, Kruse FE, Völcker HE. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci 2000; 41:692-702.
21. Lee HK, Lee KS, Kim HC, et al. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis. Am J Ophthalmol 2005; 139:965-971.
22. Lambiase A, Bonini S, Micera A, et al. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 1998; 39:1272-1275.
23. Sornelli F, Lambiase A, Mantelli F, Aloe L. NGF and NGF-receptor expression of cultured immortalized human corneal endothelial cells. Mol Vis 2010; 16:1439-1447.This article demonstrates that human endothelial cell lines produce and release NGF, and that NGF supplementation induces overexpression of NGF receptors as well as increases the synthesis and release of VEGF. This study opens new prospective in the use of NGF to modulate corneal endothelial function.
24. Kruse FE, Tseng SC. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 1993; 34:1963-1976.
25. Qi H, Chuang EY, Yoon KC, et al. Patterned expression of neurotrophic factors and receptors in human limbal and corneal regions. Mol Vis 2007; 13:1934-1941.
26. De Castro F, Silos-Santiago I, López de Armentia M, et al. Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice. Eur J Neurosci 1998; 10:146-152.
27. Joo MJ, Yuhan KR, Hyon JY, et al. The effect of nerve growth factor on corneal sensitivity after laser in situ keratomileusis. Arch Ophthalmol 2004; 122: 1338-1341.
28. Lambiase A, Micera A, Pellegrini G, et al. In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression. Invest Ophthalmol Vis Sci 2009; 50:4622-4630.
29. Muzi S, Colafrancesco V, Sornelli F, et al. Nerve growth factor in the developing and adult lacrimal glands of rat with and without inherited retinitis pigmentosa. Cornea 2010; 29:1163-1168. This study demonstrated that NGF and NGF receptors are expressed in the lacrimal gland of both normal rats and rats with inherited retinitis pigmentosa (IRP). Changes of tear secretion in IRP rats are associated with NGF pathway alteration. This study supports the hypothesis that neurotrophins play a role in modulating tear secretion.
30. Bonini S, Lambiase A, Bonini S, et al. Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int Arch Allergy Immunol 1999; 118:159-162.
31. Lambiase A, Bonini S, Bonini S, et al. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci 1995; 36:2127-2132.
32. Coassin M, Lambiase A, Costa N, et al. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye. Graefes Arch Clin Exp Ophthalmol 2005; 243:151-155.
33. Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye (Lond) 2003; 17:989-995.
34. Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea 2006; 25:352-355.
35. Cellini M, Bendo E, Bravetti GO, Campos EC. The use of nerve growth factor in surgical wound healing of the cornea. Ophthalmic Res 2006; 38:177-181.
36. Wu Y, Chu R, Zhou X, et al. Determination of the nerve growth factor level in the central cornea after LASIK and Epi-LASIK treatment in a rabbit model system. Cornea 2009; 28:1144-1148.
37. Esquenazi S, Bazan HE, Bui V, et al. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2005; 46:3121-3127.
38. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5:75-92 [review].
39. Ghinelli E, Johansson J, Riós JD, et al. Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland. Invest Ophthalmol Vis Sci 2003; 44:3352-3357.
40. Chang EJ, Im YS, Kay EP, et al. The role of nerve growth factor in hyperosmolar stress induced apoptosis. J Cell Physiol 2008; 216:69-77.
41. Liu Q, McDermott AM, Miller WL. Elevated nerve growth factor in dry eye associated with established contact lens wear. Eye Contact Lens 2009; 35:232-237.
42. Villoslada P, Hauser SL, Bartke I, et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191:1799-1806.
43. Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res 2006; 25:355-380.
44. Aloe L. Intraocular herpes simplex virus injection in neonatal rats induces sympathetic nerve cell destruction: effect of nerve growth factor. Int J Dev Neurosci 1987; 5:357-366.
45. Ungheri D, Verini MA, Ganceff L, et al. Antiviral activity of nerve growth factor in vitro. Drugs Exp Clin Res 1993; 19:151-157.
46. Laycock KA, Brady RH, Lee SF, et al. The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo. Graefes Arch Clin Exp Ophthalmol 1994; 232:421-425.
47. Mauro C, Pietro L, Emilio CC. The use of nerve growth factor in herpetic keratitis: a case report. J Med Case Rep 2007; 1:124.
48. Lambiase A, Merlo D, Mollinari C, et al. Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3. Proc Natl Acad Sci USA 2005; 102:16795-16800.
49. Li W, Sun X, Wang Z, et al. The effect of nerve growth factor on differentiation of corneal limbal epithelial cells to conjunctival goblet cells in vitro. Mol Vis 2010; 16:2739-2744.This study evaluates the effect of nerve growth factor (NGF) on the differentiation of mouse corneal limbal progenitor cells and on the expression of mucin-5AC mRNA. The authors suggest that NGF might promote the differentiation of corneal limbal progenitor cells and upregulate the expression of MUC5AC mRNA in primary culture.
50. Yamamoto N, Hirano K, Kojima H, et al. Cultured human corneal epithelial stem/progenitor cells derived from the corneal limbus. In Vitro Cell Dev Biol Anim 2010; 46:774-780. This study evaluated the change in the expression of low-affinity neurotrophin receptor p75 [p75(NTR)] of corneal epithelial stem/progenitor cells in vitro. The study showed that p75(NTR) was mainly observed in epithelial basal cells as were the corneal epithelial stem/progenitor markers p63 and integrin b1. p75(NTR).
51. Di Girolamo N, Sarris M, Chui J, et al. Localization of the low-affinity nerve growth factor receptor p75 in human limbal epithelial cells. J Cell Mol Med 2008; 12:2799-2811.
52. Lambiase A, Tirassa P, Micera A, et al. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci 2005; 46:3800-3806.
53. Lambiase A, Pagani L, Di Fausto V, et al. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res 2007; 1127:45-51.
54. Di Fausto V, Fiore M, Tirassa P, et al. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur J Neurosci 2007; 26:2473-2480.
55. Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11:551-555.
56. Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci USA 2009; 106:13469-13474.